Global Tuna Peptides (L-Anserine) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 104
Published Date: 21 Jun 2025
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
Description 
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags 
Description
According to our (Global Info Research) latest study, the global Tuna Peptides (L-Anserine) market size was valued at US$ 11.7 million in 2024 and is forecast to a readjusted size of USD 16.6 million by 2031 with a CAGR of 5.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Tuna Peptides (L-Anserine)
According to our (Global Info Research) latest study, the global Tuna Peptides (L-Anserine) market size was valued at US$ 11.7 million in 2024 and is forecast to a readjusted size of USD 16.6 million by 2031 with a CAGR of 5.3% during review period.
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
Tuna Peptides (L-Anserine) is a highly active dipeptide (β-alanyl-L-histidine) extracted from the dark muscle tissue of deep-sea tuna (such as bluefin tuna and yellowfin tuna) through bio-enzymatic hydrolysis technology. Its core functions include lowering uric acid, anti-oxidation, anti-glycation and anti-fatigue.
This report is a detailed and comprehensive analysis for global Tuna Peptides (L-Anserine) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tuna Peptides (L-Anserine) market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Tuna Peptides (L-Anserine) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Tuna Peptides (L-Anserine) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Tuna Peptides (L-Anserine) market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuna Peptides (L-Anserine)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuna Peptides (L-Anserine) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yaizu Suisankagaku Industry, Beyond Biopharma, Lankun, Rongcheng Lanrun Biological Technology, Natide (Yangjiang) Biotechnology, Guangdong Shinyee Marine Biology Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tuna Peptides (L-Anserine) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Content≥10%
Content 4%-10%
Content＜4%
Market segment by Application
Food
Health Products
Personal Care
Other
Major players covered
Yaizu Suisankagaku Industry
Beyond Biopharma
Lankun
Rongcheng Lanrun Biological Technology
Natide (Yangjiang) Biotechnology
Guangdong Shinyee Marine Biology Engineering
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuna Peptides (L-Anserine) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tuna Peptides (L-Anserine), with price, sales quantity, revenue, and global market share of Tuna Peptides (L-Anserine) from 2020 to 2025.
Chapter 3, the Tuna Peptides (L-Anserine) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuna Peptides (L-Anserine) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tuna Peptides (L-Anserine) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tuna Peptides (L-Anserine).
Chapter 14 and 15, to describe Tuna Peptides (L-Anserine) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tuna Peptides (L-Anserine) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Content≥10%
1.3.3 Content 4%-10%
1.3.4 Content＜4%
1.4 Market Analysis by Application
1.4.1 Overview: Global Tuna Peptides (L-Anserine) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Food
1.4.3 Health Products
1.4.4 Personal Care
1.4.5 Other
1.5 Global Tuna Peptides (L-Anserine) Market Size & Forecast
1.5.1 Global Tuna Peptides (L-Anserine) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Tuna Peptides (L-Anserine) Sales Quantity (2020-2031)
1.5.3 Global Tuna Peptides (L-Anserine) Average Price (2020-2031)
2.1 Yaizu Suisankagaku Industry
2.1.1 Yaizu Suisankagaku Industry Details
2.1.2 Yaizu Suisankagaku Industry Major Business
2.1.3 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Product and Services
2.1.4 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Yaizu Suisankagaku Industry Recent Developments/Updates
2.2 Beyond Biopharma
2.2.1 Beyond Biopharma Details
2.2.2 Beyond Biopharma Major Business
2.2.3 Beyond Biopharma Tuna Peptides (L-Anserine) Product and Services
2.2.4 Beyond Biopharma Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Beyond Biopharma Recent Developments/Updates
2.3 Lankun
2.3.1 Lankun Details
2.3.2 Lankun Major Business
2.3.3 Lankun Tuna Peptides (L-Anserine) Product and Services
2.3.4 Lankun Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Lankun Recent Developments/Updates
2.4 Rongcheng Lanrun Biological Technology
2.4.1 Rongcheng Lanrun Biological Technology Details
2.4.2 Rongcheng Lanrun Biological Technology Major Business
2.4.3 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Product and Services
2.4.4 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Rongcheng Lanrun Biological Technology Recent Developments/Updates
2.5 Natide (Yangjiang) Biotechnology
2.5.1 Natide (Yangjiang) Biotechnology Details
2.5.2 Natide (Yangjiang) Biotechnology Major Business
2.5.3 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Product and Services
2.5.4 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Natide (Yangjiang) Biotechnology Recent Developments/Updates
2.6 Guangdong Shinyee Marine Biology Engineering
2.6.1 Guangdong Shinyee Marine Biology Engineering Details
2.6.2 Guangdong Shinyee Marine Biology Engineering Major Business
2.6.3 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Product and Services
2.6.4 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Guangdong Shinyee Marine Biology Engineering Recent Developments/Updates
3.1 Global Tuna Peptides (L-Anserine) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Tuna Peptides (L-Anserine) Revenue by Manufacturer (2020-2025)
3.3 Global Tuna Peptides (L-Anserine) Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Tuna Peptides (L-Anserine) by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Tuna Peptides (L-Anserine) Manufacturer Market Share in 2024
3.4.3 Top 6 Tuna Peptides (L-Anserine) Manufacturer Market Share in 2024
3.5 Tuna Peptides (L-Anserine) Market: Overall Company Footprint Analysis
3.5.1 Tuna Peptides (L-Anserine) Market: Region Footprint
3.5.2 Tuna Peptides (L-Anserine) Market: Company Product Type Footprint
3.5.3 Tuna Peptides (L-Anserine) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Tuna Peptides (L-Anserine) Market Size by Region
4.1.1 Global Tuna Peptides (L-Anserine) Sales Quantity by Region (2020-2031)
4.1.2 Global Tuna Peptides (L-Anserine) Consumption Value by Region (2020-2031)
4.1.3 Global Tuna Peptides (L-Anserine) Average Price by Region (2020-2031)
4.2 North America Tuna Peptides (L-Anserine) Consumption Value (2020-2031)
4.3 Europe Tuna Peptides (L-Anserine) Consumption Value (2020-2031)
4.4 Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value (2020-2031)
4.5 South America Tuna Peptides (L-Anserine) Consumption Value (2020-2031)
4.6 Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value (2020-2031)
5.1 Global Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
5.2 Global Tuna Peptides (L-Anserine) Consumption Value by Type (2020-2031)
5.3 Global Tuna Peptides (L-Anserine) Average Price by Type (2020-2031)
6.1 Global Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
6.2 Global Tuna Peptides (L-Anserine) Consumption Value by Application (2020-2031)
6.3 Global Tuna Peptides (L-Anserine) Average Price by Application (2020-2031)
7.1 North America Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
7.2 North America Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
7.3 North America Tuna Peptides (L-Anserine) Market Size by Country
7.3.1 North America Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2031)
7.3.2 North America Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
8.2 Europe Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
8.3 Europe Tuna Peptides (L-Anserine) Market Size by Country
8.3.1 Europe Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2031)
8.3.2 Europe Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Tuna Peptides (L-Anserine) Market Size by Region
9.3.1 Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
10.2 South America Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
10.3 South America Tuna Peptides (L-Anserine) Market Size by Country
10.3.1 South America Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2031)
10.3.2 South America Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Tuna Peptides (L-Anserine) Market Size by Country
11.3.1 Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Tuna Peptides (L-Anserine) Market Drivers
12.2 Tuna Peptides (L-Anserine) Market Restraints
12.3 Tuna Peptides (L-Anserine) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Tuna Peptides (L-Anserine) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tuna Peptides (L-Anserine)
13.3 Tuna Peptides (L-Anserine) Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tuna Peptides (L-Anserine) Typical Distributors
14.3 Tuna Peptides (L-Anserine) Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables Table 1. Global Tuna Peptides (L-Anserine) Consumption Value by Type, (USD Million), 2020 & 2024 & 2031 Table 2. Global Tuna Peptides (L-Anserine) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Table 3. Yaizu Suisankagaku Industry Basic Information, Manufacturing Base and Competitors Table 4. Yaizu Suisankagaku Industry Major Business Table 5. Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Product and Services Table 6. Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 7. Yaizu Suisankagaku Industry Recent Developments/Updates Table 8. Beyond Biopharma Basic Information, Manufacturing Base and Competitors Table 9. Beyond Biopharma Major Business Table 10. Beyond Biopharma Tuna Peptides (L-Anserine) Product and Services Table 11. Beyond Biopharma Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 12. Beyond Biopharma Recent Developments/Updates Table 13. Lankun Basic Information, Manufacturing Base and Competitors Table 14. Lankun Major Business Table 15. Lankun Tuna Peptides (L-Anserine) Product and Services Table 16. Lankun Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 17. Lankun Recent Developments/Updates Table 18. Rongcheng Lanrun Biological Technology Basic Information, Manufacturing Base and Competitors Table 19. Rongcheng Lanrun Biological Technology Major Business Table 20. Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Product and Services Table 21. Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 22. Rongcheng Lanrun Biological Technology Recent Developments/Updates Table 23. Natide (Yangjiang) Biotechnology Basic Information, Manufacturing Base and Competitors Table 24. Natide (Yangjiang) Biotechnology Major Business Table 25. Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Product and Services Table 26. Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 27. Natide (Yangjiang) Biotechnology Recent Developments/Updates Table 28. Guangdong Shinyee Marine Biology Engineering Basic Information, Manufacturing Base and Competitors Table 29. Guangdong Shinyee Marine Biology Engineering Major Business Table 30. Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Product and Services Table 31. Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 32. Guangdong Shinyee Marine Biology Engineering Recent Developments/Updates Table 33. Global Tuna Peptides (L-Anserine) Sales Quantity by Manufacturer (2020-2025) & (kg) Table 34. Global Tuna Peptides (L-Anserine) Revenue by Manufacturer (2020-2025) & (USD Million) Table 35. Global Tuna Peptides (L-Anserine) Average Price by Manufacturer (2020-2025) & (US$/kg) Table 36. Market Position of Manufacturers in Tuna Peptides (L-Anserine), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024 Table 37. Head Office and Tuna Peptides (L-Anserine) Production Site of Key Manufacturer Table 38. Tuna Peptides (L-Anserine) Market: Company Product Type Footprint Table 39. Tuna Peptides (L-Anserine) Market: Company Product Application Footprint Table 40. Tuna Peptides (L-Anserine) New Market Entrants and Barriers to Market Entry Table 41. Tuna Peptides (L-Anserine) Mergers, Acquisition, Agreements, and Collaborations Table 42. Global Tuna Peptides (L-Anserine) Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR Table 43. Global Tuna Peptides (L-Anserine) Sales Quantity by Region (2020-2025) & (kg) Table 44. Global Tuna Peptides (L-Anserine) Sales Quantity by Region (2026-2031) & (kg) Table 45. Global Tuna Peptides (L-Anserine) Consumption Value by Region (2020-2025) & (USD Million) Table 46. Global Tuna Peptides (L-Anserine) Consumption Value by Region (2026-2031) & (USD Million) Table 47. Global Tuna Peptides (L-Anserine) Average Price by Region (2020-2025) & (US$/kg) Table 48. Global Tuna Peptides (L-Anserine) Average Price by Region (2026-2031) & (US$/kg) Table 49. Global Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 50. Global Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 51. Global Tuna Peptides (L-Anserine) Consumption Value by Type (2020-2025) & (USD Million) Table 52. Global Tuna Peptides (L-Anserine) Consumption Value by Type (2026-2031) & (USD Million) Table 53. Global Tuna Peptides (L-Anserine) Average Price by Type (2020-2025) & (US$/kg) Table 54. Global Tuna Peptides (L-Anserine) Average Price by Type (2026-2031) & (US$/kg) Table 55. Global Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 56. Global Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 57. Global Tuna Peptides (L-Anserine) Consumption Value by Application (2020-2025) & (USD Million) Table 58. Global Tuna Peptides (L-Anserine) Consumption Value by Application (2026-2031) & (USD Million) Table 59. Global Tuna Peptides (L-Anserine) Average Price by Application (2020-2025) & (US$/kg) Table 60. Global Tuna Peptides (L-Anserine) Average Price by Application (2026-2031) & (US$/kg) Table 61. North America Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 62. North America Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 63. North America Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 64. North America Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 65. North America Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2025) & (kg) Table 66. North America Tuna Peptides (L-Anserine) Sales Quantity by Country (2026-2031) & (kg) Table 67. North America Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2025) & (USD Million) Table 68. North America Tuna Peptides (L-Anserine) Consumption Value by Country (2026-2031) & (USD Million) Table 69. Europe Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 70. Europe Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 71. Europe Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 72. Europe Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 73. Europe Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2025) & (kg) Table 74. Europe Tuna Peptides (L-Anserine) Sales Quantity by Country (2026-2031) & (kg) Table 75. Europe Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2025) & (USD Million) Table 76. Europe Tuna Peptides (L-Anserine) Consumption Value by Country (2026-2031) & (USD Million) Table 77. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 78. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 79. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 80. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 81. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Region (2020-2025) & (kg) Table 82. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity by Region (2026-2031) & (kg) Table 83. Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value by Region (2020-2025) & (USD Million) Table 84. Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value by Region (2026-2031) & (USD Million) Table 85. South America Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 86. South America Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 87. South America Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 88. South America Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 89. South America Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2025) & (kg) Table 90. South America Tuna Peptides (L-Anserine) Sales Quantity by Country (2026-2031) & (kg) Table 91. South America Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2025) & (USD Million) Table 92. South America Tuna Peptides (L-Anserine) Consumption Value by Country (2026-2031) & (USD Million) Table 93. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Type (2020-2025) & (kg) Table 94. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Type (2026-2031) & (kg) Table 95. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Application (2020-2025) & (kg) Table 96. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Application (2026-2031) & (kg) Table 97. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Country (2020-2025) & (kg) Table 98. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity by Country (2026-2031) & (kg) Table 99. Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value by Country (2020-2025) & (USD Million) Table 100. Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value by Country (2026-2031) & (USD Million) Table 101. Tuna Peptides (L-Anserine) Raw Material Table 102. Key Manufacturers of Tuna Peptides (L-Anserine) Raw Materials Table 103. Tuna Peptides (L-Anserine) Typical Distributors Table 104. Tuna Peptides (L-Anserine) Typical Customers List of Figures Figure 1. Tuna Peptides (L-Anserine) Picture Figure 2. Global Tuna Peptides (L-Anserine) Revenue by Type, (USD Million), 2020 & 2024 & 2031 Figure 3. Global Tuna Peptides (L-Anserine) Revenue Market Share by Type in 2024 Figure 4. Content≥10% Examples Figure 5. Content 4%-10% Examples Figure 6. Content＜4% Examples Figure 7. Global Tuna Peptides (L-Anserine) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Figure 8. Global Tuna Peptides (L-Anserine) Revenue Market Share by Application in 2024 Figure 9. Food Examples Figure 10. Health Products Examples Figure 11. Personal Care Examples Figure 12. Other Examples Figure 13. Global Tuna Peptides (L-Anserine) Consumption Value, (USD Million): 2020 & 2024 & 2031 Figure 14. Global Tuna Peptides (L-Anserine) Consumption Value and Forecast (2020-2031) & (USD Million) Figure 15. Global Tuna Peptides (L-Anserine) Sales Quantity (2020-2031) & (kg) Figure 16. Global Tuna Peptides (L-Anserine) Price (2020-2031) & (US$/kg) Figure 17. Global Tuna Peptides (L-Anserine) Sales Quantity Market Share by Manufacturer in 2024 Figure 18. Global Tuna Peptides (L-Anserine) Revenue Market Share by Manufacturer in 2024 Figure 19. Producer Shipments of Tuna Peptides (L-Anserine) by Manufacturer Sales ($MM) and Market Share (%): 2024 Figure 20. Top 3 Tuna Peptides (L-Anserine) Manufacturer (Revenue) Market Share in 2024 Figure 21. Top 6 Tuna Peptides (L-Anserine) Manufacturer (Revenue) Market Share in 2024 Figure 22. Global Tuna Peptides (L-Anserine) Sales Quantity Market Share by Region (2020-2031) Figure 23. Global Tuna Peptides (L-Anserine) Consumption Value Market Share by Region (2020-2031) Figure 24. North America Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 25. Europe Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 26. Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 27. South America Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 28. Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 29. Global Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 30. Global Tuna Peptides (L-Anserine) Consumption Value Market Share by Type (2020-2031) Figure 31. Global Tuna Peptides (L-Anserine) Average Price by Type (2020-2031) & (US$/kg) Figure 32. Global Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 33. Global Tuna Peptides (L-Anserine) Revenue Market Share by Application (2020-2031) Figure 34. Global Tuna Peptides (L-Anserine) Average Price by Application (2020-2031) & (US$/kg) Figure 35. North America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 36. North America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 37. North America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Country (2020-2031) Figure 38. North America Tuna Peptides (L-Anserine) Consumption Value Market Share by Country (2020-2031) Figure 39. United States Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 40. Canada Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 41. Mexico Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 42. Europe Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 43. Europe Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 44. Europe Tuna Peptides (L-Anserine) Sales Quantity Market Share by Country (2020-2031) Figure 45. Europe Tuna Peptides (L-Anserine) Consumption Value Market Share by Country (2020-2031) Figure 46. Germany Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 47. France Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 48. United Kingdom Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 49. Russia Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 50. Italy Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 51. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 52. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 53. Asia-Pacific Tuna Peptides (L-Anserine) Sales Quantity Market Share by Region (2020-2031) Figure 54. Asia-Pacific Tuna Peptides (L-Anserine) Consumption Value Market Share by Region (2020-2031) Figure 55. China Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 56. Japan Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 57. South Korea Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 58. India Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 59. Southeast Asia Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 60. Australia Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 61. South America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 62. South America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 63. South America Tuna Peptides (L-Anserine) Sales Quantity Market Share by Country (2020-2031) Figure 64. South America Tuna Peptides (L-Anserine) Consumption Value Market Share by Country (2020-2031) Figure 65. Brazil Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 66. Argentina Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 67. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity Market Share by Type (2020-2031) Figure 68. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity Market Share by Application (2020-2031) Figure 69. Middle East & Africa Tuna Peptides (L-Anserine) Sales Quantity Market Share by Country (2020-2031) Figure 70. Middle East & Africa Tuna Peptides (L-Anserine) Consumption Value Market Share by Country (2020-2031) Figure 71. Turkey Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 72. Egypt Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 73. Saudi Arabia Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 74. South Africa Tuna Peptides (L-Anserine) Consumption Value (2020-2031) & (USD Million) Figure 75. Tuna Peptides (L-Anserine) Market Drivers Figure 76. Tuna Peptides (L-Anserine) Market Restraints Figure 77. Tuna Peptides (L-Anserine) Market Trends Figure 78. Porters Five Forces Analysis Figure 79. Manufacturing Cost Structure Analysis of Tuna Peptides (L-Anserine) in 2024 Figure 80. Manufacturing Process Analysis of Tuna Peptides (L-Anserine) Figure 81. Tuna Peptides (L-Anserine) Industrial Chain Figure 82. Sales Channel: Direct to End-User vs Distributors Figure 83. Direct Channel Pros & Cons Figure 84. Indirect Channel Pros & Cons Figure 85. Methodology Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Yaizu Suisankagaku Industry Beyond Biopharma Lankun Rongcheng Lanrun Biological Technology Natide (Yangjiang) Biotechnology Guangdong Shinyee Marine Biology Engineering
21 Jun 2025
Chemical & Material
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>
